Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults

Caterina Rosano1, Howard J Aizenstein, Minjie Wu

  • 1School of Public Health, Department of Epidemiology, University of Pittsburgh, Pennysylvania, USA. RosanoC@edc.pitt.edu

Abstract

Insights

Medial temporal lobe atrophy and brain infarcts, indicators of neurodegeneration and cerebrovascular disease, significantly increase Alzheimer's disease risk in cognitively normal older adults.

Area of Science:

  • Neurology
  • Neuroimaging
  • Geriatrics

Background:

  • Alzheimer's disease (AD) risk factors in cognitively normal individuals are crucial for early detection.
  • Medial temporal lobe (MTL) atrophy and cerebrovascular disease are potential early AD indicators.

Purpose of the Study:

  • To investigate the association between MTL atrophy, cerebrovascular disease markers (white matter hyperintensities [WMH], subclinical infarcts), and Alzheimer's disease (AD) risk.
  • To assess these associations in a cohort of cognitively normal older adults.

Main Methods:

  • 155 cognitively normal older adults underwent brain MRI to assess MTL volumes and detect WMH and subclinical infarcts.
  • Participants were followed for an average of 4.3 years with cognitive evaluations to identify AD development.
  • Statistical analysis examined the independent and combined risks associated with MTL atrophy and infarcts.

Main Results:

  • MTL atrophy and subclinical infarcts were independently associated with a significantly higher risk of developing AD.
  • Individuals with both MTL atrophy and at least one brain infarct showed a 7-fold increased risk of AD.
  • White matter hyperintensities (WMH) were also assessed but their specific association with AD risk was not detailed in the provided results.

Conclusions:

  • Both neurodegenerative markers (MTL atrophy) and cerebrovascular disease markers (infarcts) independently contribute to AD risk in cognitively normal older adults.
  • The combined presence of MTL atrophy and infarcts substantially elevates AD risk.
  • These findings highlight the importance of considering both neurodegeneration and cerebrovascular health in predicting AD development.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...